by Clinical Neuropsychologist Online | Tuesday, February 13, 2024 | Dementia
Abstract INTRODUCTION Older military veterans often present with unique and complex risk factors for Alzheimer’s disease (AD) and related dementias. Increasing veteran participation in research studies offers one avenue to advance the field and improve health...
by Clinical Neuropsychologist Online | Tuesday, February 13, 2024 | Dementia
Abstract INTRODUCTION Early cognitive decline may manifest in subtle differences in speech. METHODS We examined 238 cognitively unimpaired adults from the Framingham Heart Study (32–75 years) who completed amyloid and tau PET imaging. Speech patterns during delayed...
by Clinical Neuropsychologist Online | Monday, February 12, 2024 | Dementia
Abstract INTRODUCTION Growing evidence indicates that fine particulate matter (PM2.5) is a risk factor for Alzheimer’s disease (AD), but the underlying mechanisms have been insufficiently investigated. We hypothesized differential DNA methylation (DNAm) in brain...
by Clinical Neuropsychologist Online | Monday, February 12, 2024 | Dementia
Abstract INTRODUCTION Genetic studies conducted over the past four decades have provided us with a detailed catalog of genes that play critical roles in the etiology of Alzheimer’s disease (AD) and related dementias (ADRDs). Despite this progress, as a field we...
by Clinical Neuropsychologist Online | Friday, February 9, 2024 | Dementia
Abstract INTRODUCTION Amyloid beta (Aβ) and tau pathology are cross-sectionally associated with atrophy and cognitive decline in aging and Alzheimer’s disease (AD). METHODS We investigated relationships between concurrent longitudinal measures of Aβ (Pittsburgh...
